Rates of completion and on-target results of clinical tests
| Clinical test | Group; no. (%) of patients* | Standardized difference (95% CI) | ||
|---|---|---|---|---|
| All patients n = 66 325 | Urban n = 28 969 | Rural n = 37 356 | ||
| HbA1c | ||||
| Test completed | 51 007 (76.9) | 22 085 (76.2) | 28 922 (77.4) | 0.028 (0.013 to 0.043) |
| Result, %, mean ± SD† | 7.35 ± 1.49 | 7.26 ± 1.50 | 7.41 ± 1.49 | 0.095 (0.077 to 0.113) |
| Result on target† | 26 157 (51.3) | 11 877 (53.8) | 14 280 (49.4) | 0.088 (0.071 to 0.106) |
| Low-density lipoprotein cholesterol | ||||
| Test completed | 45 268 (68.3) | 19 878 (68.6) | 25 390 (68.0) | 0.014 (−0.001 to 0.029) |
| Result, mmol/L, mean ± SD† | 2.41 ± 0.95 | 2.36 ± 0.94 | 2.46 ± 0.95 | 0.107 (0.088 to 0.126) |
| Result on target† | 17 175 (37.9) | 8119 (40.8) | 9056 (35.7) | 0.107 (0.088 to 0.125) |
| Urine albumin-to-creatinine ratio | ||||
| Test completed | 22 676 (34.2) | 10 148 (35.0) | 12 528 (33.5) | 0.031 (0.016 to 0.047) |
| Result, mg/mmol, median (IQR)† | 1.7 (0.8 to 5.4) | 1.6 (0.8 to 5.1) | 1.7 (0.8 to 5.6) | 0.020 (−0.006 to 0.046) |
| Result on target† | 12 429 (54.8) | 5708 (56.2) | 6721 (53.6) | 0.052 (0.026 to 0.078) |
Note: CI = confidence interval, HbA1c = glycated hemoglobin, IQR = interquartile range, SD = standard deviation.
↵* Except where indicated otherwise.
↵† Mean or median result and percentage on target were calculated in relation to number of patients with the particular test completed in the study period. Mean and median values were calculated using individuals’ most recent test results completed in the study period.